Premium
Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies Treatment
Author(s) -
Foltynie Tom,
Athauda Dilan
Publication year - 2018
Publication title -
movement disorders clinical practice
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.754
H-Index - 18
ISSN - 2330-1619
DOI - 10.1002/mdc3.12611
Subject(s) - medicine , lixisenatide , exenatide , disease , diabetes mellitus , glucagon like peptide 1 receptor , synucleinopathies , intensive care medicine , type 2 diabetes , bioinformatics , parkinson's disease , endocrinology , alpha synuclein , receptor , biology , agonist
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom